F. Joel Leong

925 total citations
11 papers, 467 citations indexed

About

F. Joel Leong is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, F. Joel Leong has authored 11 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 4 papers in Oncology and 4 papers in Computational Theory and Mathematics. Recurrent topics in F. Joel Leong's work include Malaria Research and Control (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Computational Drug Discovery Methods (4 papers). F. Joel Leong is often cited by papers focused on Malaria Research and Control (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Computational Drug Discovery Methods (4 papers). F. Joel Leong collaborates with scholars based in Singapore, United States and China. F. Joel Leong's co-authors include Thierry T. Diagana, Baldur Magnusson, Jay Prakash Jain, Ruobing Li, Gilbert Lefèvre, Peter Pertel, François Nosten, Nicholas J. White, Aung Pyae Phyo and Sasithon Pukrittayakamee and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

F. Joel Leong

11 papers receiving 462 citations

Peers

Countries citing papers authored by F. Joel Leong

Since Specialization

Citations

This map shows the geographic impact of F. Joel Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Joel Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Joel Leong more than expected).

Fields of papers citing papers by F. Joel Leong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Joel Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Joel Leong. The network helps show where F. Joel Leong may publish in the future.

Co-authorship network of co-authors of F. Joel Leong

This figure shows the co-authorship network connecting the top 25 collaborators of F. Joel Leong. A scholar is included among the top collaborators of F. Joel Leong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Joel Leong. F. Joel Leong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study 2020 ·Clinical Infectious Diseases ·James G. Kublin, Sean C. Murphy, Janine Maenza, Annette M. Seilie, Jay Prakash Jain, (unknown), (unknown), Rong Zhao, Rachel L. Soon, Julie Czartoski, (unknown), Elizabeth R. Duke, Ming Chang, Ashley M. Vaughan, Stefan H. I. Kappe, F. Joel Leong, Peter Pertel, William Prince, (unknown)	16
2	A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine 2018 ·Malaria Journal ·F. Joel Leong, Jay Prakash Jain, (unknown), (unknown), Daniel S. Stein	16
3	Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers 2017 ·Antimicrobial Agents and Chemotherapy ·Jay Prakash Jain, F. Joel Leong, Lan Chen, (unknown), Vishal Koradia, Daniel S. Stein, (unknown), Gangadhar Sunkara, (unknown)	29
4	Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria 2016 ·New England Journal of Medicine ·Nicholas J. White, Tran Thanh Duong, Chirapong Uthaisin, François Nosten, Aung Pyae Phyo, Borimas Hanboonkunupakarn, Sasithon Pukrittayakamee, Podjanee Jittamala, (unknown), (unknown), (unknown), Ruobing Li, Baldur Magnusson, (unknown), Daniela Wieser, (unknown), Rong Zhao, Thierry T. Diagana, Peter Pertel, F. Joel Leong	71
5	Cryptosporidiosis Drug Discovery: Opportunities and Challenges 2016 ·ACS Infectious Diseases ·Ujjini H. Manjunatha, Alexander T. Chao, F. Joel Leong, Thierry T. Diagana	35
6	Spiroindolone KAE609 for Falciparum and Vivax Malaria 2014 ·New England Journal of Medicine ·Nicholas J. White, Sasithon Pukrittayakamee, Aung Pyae Phyo, Ronnatrai Rueangweerayut, François Nosten, Podjanee Jittamala, Atthanee Jeeyapant, Jay Prakash Jain, Gilbert Lefèvre, Ruobing Li, Baldur Magnusson, Thierry T. Diagana, F. Joel Leong	163
7	A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers 2014 ·Antimicrobial Agents and Chemotherapy ·F. Joel Leong, Rong Zhao, (unknown), Baldur Magnusson, Thierry T. Diagana, Peter Pertel	38
8	Protocol No. CKAE609X2201A proof-of-concept open label, 3-day repeated dose study to assess efficacy, safety, tolerability and pharmacokinetics of KAE609 in adult patients with acute, uncomplicated Plasmodium falciparum or vivax malaria mono-infection 2014 ·F. Joel Leong, Gilbert Lefèvre, Baldur Magnusson	1
9	A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers 2014 ·Antimicrobial Agents and Chemotherapy ·F. Joel Leong, Ruobing Li, Jay Prakash Jain, Gilbert Lefèvre, Baldur Magnusson, Thierry T. Diagana, Peter Pertel	73
10	Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia 2011 ·The International Journal of Tuberculosis and Lung Disease ·Muhammad Nasrum Massi, Sitti Wahyuni, (unknown), (unknown), Irawan Yusuf, F. Joel Leong, Thomas Dick, (unknown)	22
11	Comprar A Color Atlas Of Comparative Pathology Of Pulmonary Tuberculosis \| F. Leong \| 9781439835272 \| CRC PRESS 2010 ·F. Joel Leong, Véronique Dartois, Thomas Dick	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact